-
1
-
-
0027980646
-
Patient characteristics associated with high-risk methotrexate concentrations and toxicicy
-
Relling MV, Fairclough D, Ayers D, Crom R, Rodman JH, Ching-Hon Pui, et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicicy. J Clin Oncol 1994; 8: 1667-72.
-
(1994)
J Clin Oncol
, vol.8
, pp. 1667-1672
-
-
Relling, M.V.1
Fairclough, D.2
Ayers, D.3
Crom, R.4
Rodman, J.H.5
Pui, C.-H.6
-
2
-
-
0033621556
-
Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia
-
Wall AM, Gajjar A, Link A, Mahmoud H, Pui CH, Relling MV. Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia. Leukemia 2000; 14 (2): 221-5.
-
(2000)
Leukemia
, vol.14
, Issue.2
, pp. 221-225
-
-
Wall, A.M.1
Gajjar, A.2
Link, A.3
Mahmoud, H.4
Pui, C.H.5
Relling, M.V.6
-
4
-
-
0003785851
-
-
Micromedex Inc. Denver, Colorado. Drug Evaluation Methotrexate
-
DrugDex® Information System. Micromedex Inc. Denver, Colorado 2000. Drug Evaluation Methotrexate.
-
(2000)
DrugDex® Information System
-
-
-
5
-
-
0025163171
-
Rescue after intermediate and high-dose methotrexate: Background, rationale and current practice
-
Borsi JD, Sagen E, Romslo I, Moe PJ. Rescue after intermediate and high-dose methotrexate: background, rationale and current practice. Pediatric Hematology and Oncology 1990; 7: 374-63.
-
(1990)
Pediatric Hematology and Oncology
, vol.7
, pp. 374-363
-
-
Borsi, J.D.1
Sagen, E.2
Romslo, I.3
Moe, P.J.4
-
7
-
-
0031806321
-
Succesful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure
-
Kepka L, De Lassence A, Ribrag V, Gachot B, Blot F, Theodore C, et al. Succesful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure. Leuk Lymphoma 1998; 29 (1-2): 205-9.
-
(1998)
Leuk Lymphoma
, vol.29
, Issue.1-2
, pp. 205-209
-
-
Kepka, L.1
De Lassence, A.2
Ribrag, V.3
Gachot, B.4
Blot, F.5
Theodore, C.6
-
8
-
-
0033304167
-
Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach
-
Abstract
-
Odoul F, Le Guellec C, Lamagnere JP, Breilh D, Saux MC, Paintaud G, et al. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach. (Abstract) Fundam Clin Pharmacol 1999; 13(5): 495-604.
-
(1999)
Fundam Clin Pharmacol
, vol.13
, Issue.5
, pp. 495-604
-
-
Odoul, F.1
Le Guellec, C.2
Lamagnere, J.P.3
Breilh, D.4
Saux, M.C.5
Paintaud, G.6
-
9
-
-
0023939246
-
High-dose methotrexate: Pharmacokinetics in children and young adults
-
Raude E, Oellerich M, Weinel P, Freund M, Shrappe M, Riehm H, et al. High-dose methotrexate: pharmacokinetics in children and young adults. International Journal of Clinical Pharmacology, Therapy and Toxicology 1988; 7: 364-70.
-
(1988)
International Journal of Clinical Pharmacology, Therapy and Toxicology
, vol.7
, pp. 364-370
-
-
Raude, E.1
Oellerich, M.2
Weinel, P.3
Freund, M.4
Shrappe, M.5
Riehm, H.6
-
10
-
-
0036035302
-
Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma
-
Rousseau A, Sabot C, Delepine N, Delepine G, Debord J, Lachatre G, et al. Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma. Clin Pharmacokinet 2002; 41 (13): 1095-104.
-
(2002)
Clin Pharmacokinet
, vol.41
, Issue.13
, pp. 1095-1104
-
-
Rousseau, A.1
Sabot, C.2
Delepine, N.3
Delepine, G.4
Debord, J.5
Lachatre, G.6
-
11
-
-
0035987504
-
Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer
-
Monjanel-Mouterde S, Lejeune C, Ciccolini J, Merite N, Hadjaj D, Bonnier P, et al. Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer. J Clin Pharm Ther 2002; 27 (3): 189-95.
-
(2002)
J Clin Pharm Ther
, vol.27
, Issue.3
, pp. 189-195
-
-
Monjanel-Mouterde, S.1
Lejeune, C.2
Ciccolini, J.3
Merite, N.4
Hadjaj, D.5
Bonnier, P.6
-
13
-
-
0030611877
-
Carboxypeptidasa-G2, thymidine, and leucovorin rescue in cancer patients with methtrexate-induced renal dysfunction
-
Widemann BC, Balis PM, Murphy RF, Sorensen JM, Montello MJ, O'Brien M, et al. Carboxypeptidasa-G2, thymidine, and leucovorin rescue in cancer patients with methtrexate-induced renal dysfunction. J Clin Oncol 1997; 15 (5): 2125-34.
-
(1997)
J Clin Oncol
, vol.15
, Issue.5
, pp. 2125-2134
-
-
Widemann, B.C.1
Balis, P.M.2
Murphy, R.F.3
Sorensen, J.M.4
Montello, M.J.5
O'Brien, M.6
-
14
-
-
0035024216
-
Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure
-
Van den Bongard HJ, Mathjt RA, Boogerd W, Schornagel JH, Soesan M, Schellens JH, et al. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure. Cancer Chemother Pharmacol 2001; 47 (6): 537-40.
-
(2001)
Cancer Chemother Pharmacol
, vol.47
, Issue.6
, pp. 537-540
-
-
Van Den Bongard, H.J.1
Mathjt, R.A.2
Boogerd, W.3
Schornagel, J.H.4
Soesan, M.5
Schellens, J.H.6
|